Michael Caramian Cochran

USPTO Granted Patents = 34 (Patent Applications = 28)

EPO Patents = 1 (Patent Applications = 13)

Average Co-Inventor Count = 5.2

ph-index = 11

Forward Citations = 342(Granted Patents)

Location History:

San Diego, CA (US) (2022 - 2023)
La Jolla, CA (US) (2019 - 2024)
Galena, OH (US) (2024)

Company Filing History:

32 out of 47

Avidity Biosciences, Inc.

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427202 - Compositions and methods of treating muscle dystrophy (2025-09-30),

2. 12365704 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-22),

3. 12364769 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-22),

4. 12359202 - Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping (2025-07-15),

5. 12351637 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-08),

6. 12263224 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2025-04-01),

7. 12234290 - Nucleic acid-polypeptide compositions and uses thereof (2025-02-25),

8. D1042125 - Beverage can seal (2024-09-17),

9. 12071621 - Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping (2024-08-27),

10. 12064483 - Nucleic acid-polypeptide compositions and methods of inducing exon skipping (2024-08-20),

11. 12006499 - Una amidites and uses thereof (2024-06-11),

12. 11872287 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2024-01-16),

13. 11712478 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2023-08-01),

14. 11707532 - Compositions and methods of treating muscle dystrophy (2023-07-25),

15. 11583591 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2023-02-21),

Title: Michael Caramian Cochran: Pioneering Innovation Through Inventiveness

Introduction:

Michael Caramian Cochran, a visionary inventor based in La Jolla, California, has carved a significant path in the world of innovation. With 23 patents to his name, Cochran's forward-thinking approach and unconventional ideas have positioned him as a leading figure in the realm of inventors.

Latest Patents:

Among Cochran's latest patents are revolutionary compositions and methods for treating muscle atrophy and myotonic dystrophy. These groundbreaking solutions include polynucleic acid molecules, pharmaceutical compositions, and innovative treatment methods, offering promising advancements in the medical field.

Career Highlights:

Throughout his illustrious career, Cochran has made notable contributions to companies such as Avidity Biosciences, Inc. and Rohr, Inc. His expertise and dedication to innovation have led to the development of cutting-edge technologies that address crucial challenges in various industries.

Collaborations:

Cochran has collaborated with esteemed professionals in his field, including coworkers Venkata Ramana Doppalapudi and Rob Burke. Together, they have worked towards pushing the boundaries of what is possible, fueling creativity and progress in the field of invention.

Conclusion:

Michael Caramian Cochran's relentless pursuit of innovation and his ability to think beyond traditional boundaries have established him as a trailblazer in the world of inventors. His remarkable achievements and groundbreaking patents continue to inspire future generations of inventors and innovators, shaping the landscape of creativity and progress in the industry.

This text is generated by artificial intelligence and may not be accurate.